Latest News about HGEN
Recent news which mentions HGEN
Insiders Buying These 4 Penny Stocks
March 07, 2022
From Benzinga
80 Biggest Movers From Yesterday
March 02, 2022
From Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
March 01, 2022
From Benzinga
25 Stocks Moving in Monday's Pre-Market Session
February 14, 2022
From Benzinga
52 Weeks High And Low Article
February 11, 2022
From Benzinga
Humanigen, Cenexi Ink Manufacture Pact For COVID-19 Candidate, Lenzilumab, In France
February 09, 2022
Tickers
HGEN
From Benzinga
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
February 09, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 08, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 04, 2022
From Benzinga
20 Stocks Moving in Monday's Pre-Market Session
January 10, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
January 07, 2022
From Benzinga
Stocks Hitting New 52-Week Lows Today
January 03, 2022
From Benzinga
65 Biggest Movers From Yesterday
December 21, 2021
From Benzinga
After FDA Rejection, Humanigen's COVID-19 Drug Hopeful Sees Some Light Of Good News
December 02, 2021
Tickers
HGEN
From Benzinga
27 Stocks Moving in Thursday's Pre-Market Session
December 02, 2021
From Benzinga
These Biotech Companies Are Attempting to Use Improved Antibody Technology in the Fight To Eradicate COVID-19
November 29, 2021
From Benzinga
20 Stocks Moving in Monday's Pre-Market Session
November 29, 2021
From Benzinga
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
November 11, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 08, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
From Benzinga
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
From Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
From Benzinga
60 Biggest Movers From Friday
September 13, 2021
From Benzinga
The Week Ahead In Biotech (Sept. 12-18): Calliditas FDA Decision, Adcom Review For Pfizer/BioNTech COVID-19 Vaccine, Oncology Conference And IPOs
September 12, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
September 10, 2021
From Benzinga